CI
HALO icon

Cowen Inc’s Halozyme HALO Stock Holding History

Cowen Inc’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-200
Closed -$259K – 335
2017
Q1 		$259K Buy
+200
New +$2.53K 0.01% 199

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cowen Inc's HALO Position: Q2 2017 in Review

Cowen Inc sold out of Halozyme (HALO) in Q2 2017, closing a stake of 2,000 shares — an estimated $26K sold.

Cowen Inc first reported a position in HALO in Q1 2014 and held it in 3 quarters. The position peaked at $201K in Q1 2014. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • Cowen Inc reported no remaining Halozyme position as of Q2 2017 after selling out during the quarter.
  • Cowen Inc sold 2,000 Halozyme shares in Q2 2017, an estimated $26K.
  • Cowen Inc first reported a position in Halozyme in Q1 2014 and held it in 3 quarters.
  • Cowen Inc's Halozyme position peaked at $201K in Q1 2014.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Cowen Inc's 13F filing for Q2 2017, filed 10 Aug 2017.